Microbot Medical
MBOT

Microbot Medical (MBOT) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
B. Riley SecuritiesMaintainedBuy$4.00 from $5.00Aug 14, 2026
LUCID CAPITAL MARKETSInitiated CoverageBuy$4.00Jun 3, 2026
HC Wainwright & Co.MaintainedBuy$12.00Apr 14, 2026
B. Riley SecuritiesInitiated CoverageBuy$5.00Feb 10, 2026
Roth CapitalInitiated CoverageBuy$5.50Dec 3, 2025
HC Wainwright & Co.MaintainedBuy$12.00Nov 28, 2025
HC Wainwright & Co.MaintainedBuy$12.00Oct 15, 2025
HC Wainwright & Co.MaintainedBuy$12.00 from $9.00Sep 11, 2025
HC Wainwright & Co.MaintainedBuy$9.00Apr 10, 2025
HC Wainwright & Co.MaintainedBuy$9.00 from $7.00Jan 24, 2025
HC Wainwright & Co.MaintainedBuy$7.00Jun 3, 2024
HC Wainwright & Co.MaintainedBuy$7.00 from $8.00Apr 16, 2024
HC Wainwright & Co.MaintainedBuy$8.00Oct 18, 2023
HC Wainwright & Co.MaintainedBuy$8.00Jun 26, 2023
HC Wainwright & Co.MaintainedBuy$8.00Jun 6, 2023
HC Wainwright & Co.MaintainedBuy$8.00 from $20.00May 9, 2023

Frequently asked questions

  • What is the latest analyst rating on MBOT?

    On Aug 14, 2026, B. Riley Securities maintained Microbot Medical at Buy with a price target of $4.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.